Table 1.
Regulatory effects of lncRNAs pathways in anti-CoV immune response.
Human coronavirus | Signal pathways | Target | lncRNAs | Function | Immune reaction | References |
---|---|---|---|---|---|---|
SARS-CoV-2 | IFN | IFN- γ | LINC02384 | Antiviral response | Innate Immune | (8) |
IFN-I | EGOT | Antiviral response | Innate Immune | (42) | ||
NLRP3 | CAPN1 | MALAT1, NEAT1 | Inflammation | Innate and adaptive immune | (8) | |
IL-17 | IL-17 | AL392172, HOTAIRM1, PVT1 | Viral transcription and Inflammation | Innate and adaptive immune | (8) | |
Cytokine | IL-6, TNF-α | WAKMAR2, EGOT, EPB41L4A-AS1, ENSG00000271646 | Immune and inflammatory responses | Innate and adaptive immune | (42) | |
Th17 cell differentiation | SATB1, LEF1, IL6ST, CCR7 | CCR7-AS-1, LEF1-AS-1, LINC-CCR7-2, LINC-TCF7-1, TCF7-AS -1 | T cell activation and differentiation | Adaptive immune | (43) | |
MAPK | AP-1 | LINC-JUND-1, LINC-HSP90AA1-1, HIF1A-AS-1, RORA-AS-7, RORA-AS-8 | T cell activation and differentiation | Adaptive immune | (43) | |
AKT, PAK, ERK | IL-6 | NORAD, RAD51-AS1 | Cytokine storm and Inflammation | Innate and adaptive immune | (44) | |
TNFα | NORAD, RAD51-AS1, GAS5 | Cytokine storm and Inflammation | Innate and adaptive immune | (44) | ||
Akt/mTOR | TNFRSF1B, FCGR2A | MSTRG.119845.30 | Sustained T cell and B cell responses | Adaptive immune | (45) | |
STAT3 | MSTRG.106112.2 | Block virus autophagy and apoptosis | Innate and adaptive immune | (45) | ||
NF-κB | IL-6, TNF, NF-κB1 | MALAT1, WAKMAR2, EGOT, DANCR, NONHSAT122723.2 | Inflammation | Innate and adaptive immune | (8, 42, 46, 47) | |
P13K/AKT | IL1RN | ENST00000631362 | Inflammation | Innate and adaptive immune | (47) | |
SARS-CoV | IFN | ISGs | NEAT1, Adapt33 | limit viral replication within the cells | Innate Immune | (37) |
IFN-α | Gm26917 | Antiviral response | Innate Immune | (48) | ||
TGF-β | SMAD2, SMAD3, SMAD4, SMAD7, and TGFBR1 | SNHG1, SMC2-AS1 | Promote virus infection | Innate and adaptive immune | (49) |